GlycA Is a Novel Biomarker of Inflammation and Subclinical Cardiovascular Disease in Psoriasis

RATIONALE: GlycA, an emerging inflammatory biomarker, predicted cardiovascular events in population-based studies. Psoriasis, an inflammatory disease associated with increased cardiovascular risk, provides a model to study inflammatory biomarkers in cardiovascular disease (CVD). Whether GlycA associ...

Full description

Saved in:
Bibliographic Details
Published in:Circ Res
Main Authors: Joshi, Aditya A., Lerman, Joseph B., Aberra, Tsion M., Afshar, Mehdi, Teague, Heather L., Rodante, Justin A., Krishnamoorthy, Parasuram, Ng, Qimin, Aridi, Tarek Z., Salahuddin, Taufiq, Natarajan, Balaji, Lockshin, Benjamin N., Ahlman, Mark A., Chen, Marcus Y., Rader, Daniel J., Reilly, Muredach P., Remaley, Alan T., Bluemke, David A., Playford, Martin P., Gelfand, Joel M., Mehta, Nehal N.
Format: Artigo
Language:Inglês
Published: 2016
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5215065/
https://ncbi.nlm.nih.gov/pubmed/27654120
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCRESAHA.116.309637
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items